Pier Selenica

Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway

Zhiqiang Li, Pedram Razavi, Qing Li et al. · Cancer Cell · 2018 · 491 citations · Full text

Tumor Biology, Hippo Pathway, Signaling Pathway +8

Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer

Kevin Boehm, Emily A. Aherne, Lora H. Ellenson et al. · Nature Cancer · 2022 · 315 citations · Full text

Diverse <i>BRCA1</i> and <i>BRCA2</i> Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer

Britta Weigelt, Iñaki Comino‐Méndez, Ino de Bruijn et al. · Clinical Cancer Research · 2017 · 247 citations

Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy

Alejandro Jiménez-Sánchez, Paulina Cybulska, Katherine LaVigne Mager et al. · Nature Genetics · 2020 · 239 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Medicine +8

The genetic landscape of endometrial clear cell carcinomas

Deborah F. DeLair, Kathleen A. Burke, Pier Selenica et al. · The Journal of Pathology · 2017 · 225 citations · Full text